~~<i id='2F8A46FFE5'><strike id='2F8A46FFE5'><tt id='2F8A46FFE5'><pre id='2F8A46FFE5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：focus 2025-09-30 00:03:31 - browse：427

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Biotech stock slump in 2023: awaiting the turnaround

leisure time

entertainment

explore

focus

entertainment

MarkSchiefelbein/APNortheasternUniversityhasbeenselectedforaleadingroleinanewnationalnetworkformedto

WSS

Why are Kaiser Permanente staff considering a strike?

Alnylam reports growth in sales of rare disease treatments

Alnylam reports growth in sales of rare disease treatments

Biotech stock slump in 2023: awaiting the turnaround

Personalized medicine goes far beyond genetics

How AI helped researchers track recovery from depression

hotspot

hotspot

leisure time

What does generative AI mean for health care? We asked experts

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Guidelines to prevent youth baseball injuries need more muscle

Medical student insurance fails on mental health care coverage

Supreme Court strikes down use of affirmative action

CommonSpirit Health keeps growing, even as it loses money

New air purifier tech could be key to improving indoor air quality

H.R. 3 is the wrong path to lower drug costs

How to save PrEP access — and even expand it

A controversial new treatment promises to make little people taller

entertainment

Personalized medicine goes far beyond genetics

CDC's new outbreak response network to include Northeastern

'Null' research findings aren't empty of meaning. Let's publish them

It costs an awful lot of money to give away a kidney

Medical student insurance fails on mental health care coverage

CDC advisers recommend seasonal use of Pfizer RSV shot

explore

explore

focus

entertainment